✦ LIBER ✦

PCV63 COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION IN THE NETHERLANDS

✍ Scribed by BA van Hout; MJD Tangelder; P Bervoets; S Gabriel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV7 THE COST-EFFECTIVENESS OF CLOPIDOGR

✍ A Pietrasik; M Niewada; J Spiesser; S Gabriel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCV1 COST-EFFECTIVENESS ANALYSIS OF CLOP

✍ K Borsos; B Nagy; J Spiesser; S Gabriel; G Blaskó 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Modeling the cost-effectiveness of clopi

✍ Peter Lindgren; Bengt Jonsson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

PCV5 LONG-TERM COST-EFFECTIVENESS OF CLO

✍ B Brüggenjürgen; B Ehlken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Long-term cost-effectiveness of clopidog

✍ B. Brüggenjürgen; P. Lindgren; B. Ehlken; H.-J. Rupprecht; S. N. Willich 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 178 KB

Long-term cost-effectiveness of clopidog

✍ William S. Weintraub; Elizabeth M. Mahoney; Andre Lamy; Steven Culler; Yong Yuan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 222 KB